.png)
Artificial intelligence is rapidly transforming the healthcare industry. Hospitals, physician groups, insurers, and healthcare technology vendors are increasingly integrating AI tools into clinical work-flows and administrative processes. And with good reason. AI offers powerful opportunities to im-prove efficiency and patient outcomes, including everything from diagnostic support and predictive analytics to automated documentation and virtual assistants.
At the same time, the use of AI in healthcare raises significant legal risks, particularly with respect to patient confidentiality. As healthcare organizations adopt these tools, protecting sensitive health information must remain a central consideration.
Healthcare entities already operate within one of the most stringent privacy frameworks in any in-dustry. The Health Insurance Portability and Accountability Act (HIPAA), along with numerous state privacy laws, imposes strict requirements on how protected health information (PHI) may be used, stored, and shared. When AI systems are introduced into the environment, the risk landscape changes in ways that many organizations are only beginning to understand.
How AI is Being Used Across Healthcare Operations
AI technologies are now embedded in many aspects of healthcare delivery. Common applications include:
While these tools can increase efficiency and support better clinical decision-making, they often require access to large volumes of patient data in order to function effectively. In many cases, that data includes PHI.
The challenge arises when healthcare organizations adopt AI platforms, particularly generative AI tools, without fully evaluating how patient information may be processed, stored, or transmitted.
Where Confidentiality Risks Arise
AI-related confidentiality risks can emerge in several ways.
Unintended Data Disclosure
Some AI platforms store user inputs in order to improve their underlying models. If a healthcare provider enters identifiable patient information into such a system, that data may be retained outside the organization’s secure environment. In certain cases, the information could potentially be incor-porated into future outputs or accessed by third parties.
Third-Party Vendor Exposure
Many AI solutions are offered through third-party vendors. When those vendors have access to PHI, they may qualify as “business associates” under HIPAA, which requires formal Business As-sociate Agreements (BAAs) and strict compliance with privacy and security standards.
Data Aggregation and Re-Identification
AI systems often rely on large datasets that combine information from multiple sources. Even when patient information has been de-identified, there remains a possibility that individuals could be re-identified through sophisticated data analysis techniques.
Internal Use Without Governance
Another emerging risk involves internal experimentation with AI tools. Healthcare professionals may begin using generative AI systems to summarize draft clinical notes or assist with administra-tive tasks.
Regulatory Scrutiny Is Increasing
Regulators are beginning to pay very close attention to the concerns around AI and healthcare pri-vacy.
The U.S. Department of Health and Human Services (HHS) has begun examining how existing HIPAA rules apply to emerging AI technologies. At the same time, the Federal Trade Commission (FTC) has signaled that it will pursue enforcement actions against companies that misuse or inade-quately protect health-related data.
In addition, many states are expanding consumer data privacy laws that include health-related in-formation. These evolving regulatory structures may impose additional obligations on healthcare entities using AI tools.
Practical Steps for Healthcare Organizations
Healthcare organizations can take several steps to reduce confidentiality risks while still benefiting from AI innovation.
Establish Clear AI Governance Policies
Organizations should develop internal policies governing when and how AI tools may be used. These policies should address whether employees may use generative AI systems, what types of information may be entered into those platforms, and what approval processes must be followed. Clear guidelines can prevent well-intentioned employees from inadvertently exposing patient in-formation.
Conduct Vendor Due Diligence
Before implementing AI solutions, organizations should thoroughly evaluate vendors’ data security practices. Important questions include:
Robust vendor review processes are essential to mitigating third-party risk.
Limit Data Exposure
Whenever possible, organizations should minimize the amount of PHI shared with AI systems. In some cases, data can be de-identified or anonymized before being used for AI-driven analysis.
Train Employees on Responsible AI Use
Education is another critical component of risk management. Healthcare professionals should un-derstand that entering patient information into consumer-grade AI tools may violate privacy obliga-tions.
Preparing for Responsible AI Adoption is Essential
Artificial intelligence will undoubtedly play an increasingly significant role in the future of healthcare. The technology offers enormous potential to enhance diagnostics, improve operational efficiency, streamline clinical workflows, and support better patient care. But the rapid pace of in-novation should not outstrip careful consideration of patient privacy.
Healthcare organizations that approach AI adoption with thoughtful governance and clear privacy safeguards will be better positioned to harness the benefits of AI while protecting one of the indus-try’s most important obligations—maintaining the confidentiality of patient information.
For more information about the legal risks associated with artificial intelligence in healthcare or guidance on protecting patient confidentiality when implementing AI tools, please contact Danielle Glover.
